---
document_datetime: 2023-09-21 18:51:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/neupopeg-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: neupopeg-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.13215
conversion_datetime: 2025-12-20 17:01:27.133229
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Procedural steps taken after granting the Marketing Authorisation

For procedures finalised after 1 February 2004 please refer to module 8B

| Scope                                                                                                                          | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|--------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Transfer of Marketing Authorisation Holder                                                                                     | T/01                 | T                        | 20.12.02                            | 27.01.03                                |
| Update of or change(s) to the pharmaceutical documentation and Change(s) to the manufacturing process for the active substance | II/02                | II                       | 22.05.03                            | 02.06.03                                |
| Update of Summary of Product Characteristics and Package Leaflet                                                               | II/03                | II                       | 20.11.03                            | 29.01.04                                |
| Update of or change(s) to the pharmaceutical documentation                                                                     | II/04                | II                       | 17.12.03                            | 15.01.04                                |

In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

<!-- image -->

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.